Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Mateon Therapeutics Inc. buy klostergang

Mateon Therapeutics Inc.
Start price
€1.36
03.06.15 / 50%
Target price
€1.70
07.12.15
Performance (%)
-39.82%
End price
€0.82
07.12.15
Summary
This prediction ended on 07.12.15 with a price of €0.82. The BUY prediction by klostergang for Mateon Therapeutics Inc. performed very badly with a performance of -39.82%. klostergang has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Mateon Therapeutics Inc. - - - -
iShares Core DAX® 0,44 % 5,64 % 7,81 % 63,64 %
iShares Nasdaq 100 1,06 % 0,28 % 27,24 % 88,12 %
iShares Nikkei 225® 1,77 % 0,41 % 49,27 % 83,53 %
iShares S&P 500 0,37 % 1,92 % 22,34 % 68,75 %

Comments by klostergang for this prediction

In the thread Mateon Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -39.82%
Target price 1.700
Change
Ends at 07.12.15

Die FDA billigt PFS als primären Endpunkt der Phase-3-Studie :

http://seekingalpha.com/article/3228966-there-is-significant-upside-ahead-for-oxigene

klostergang 
0
Report Share
03.06.15
Prediction Buy
Perf. (%) -39.82%
Target price 1.700
Change
Ends at 07.12.15

(Vom Mitglied beendet)

klostergang 
0
Report Share
07.12.15